Literature DB >> 23975634

EMT transcription factors: implication in osteosarcoma.

Guoqiong Yang1, Jian Yuan, Kanghua Li.   

Abstract

The primary malignant bone tumor, osteosarcoma, is a deadly disorder. Its etiology is complex, and treatment is mostly obscure. The transcription factors (TFs) involved in epithelial to mesenchymal transition (EMT) have significant role in osteosarcoma. A number of evidence suggests that overexpression of EMT-TFs, such as Twist, Snails and Zebs, is involved in complex pathogenesis of osteosarcoma. Recent research studies have showed some extent of promise in osteosarcoma treatment by targeting these EMT-TFs. However, success in research on osteosarcoma-EMT-TFs axis is just in primary stage, and a long way to go. Targeting Twist, Snail or Zeb by specific molecules or chemotherapeutic agents may provide a new dimension in osteosarcoma treatment by controlling metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975634     DOI: 10.1007/s12032-013-0697-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  52 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Expanding roles of ZEB factors in tumorigenesis and tumor progression.

Authors:  Ester Sánchez-Tilló; Laura Siles; Oriol de Barrios; Miriam Cuatrecasas; Eva C Vaquero; Antoni Castells; Antonio Postigo
Journal:  Am J Cancer Res       Date:  2011-08-20       Impact factor: 6.166

Review 3.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

4.  RLIM interacts with Smurf2 and promotes TGF-β induced U2OS cell migration.

Authors:  Yongsheng Huang; Yang Yang; Rui Gao; Xianmei Yang; Xiaohua Yan; Chenji Wang; Sirui Jiang; Long Yu
Journal:  Biochem Biophys Res Commun       Date:  2011-09-17       Impact factor: 3.575

Review 5.  Etiology of osteosarcoma.

Authors:  Bruno Fuchs; Douglas J Pritchard
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

Review 6.  Current treatment of osteosarcoma.

Authors:  W S Ferguson; A M Goorin
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

7.  Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas.

Authors:  Helena Wensman; Hanna Göransson; Karl-Johan Leuchowius; Sara Strömberg; Fredrik Pontén; Anders Isaksson; Gerard Roel Rutteman; Nils-Erik Heldin; Gunnar Pejler; Eva Hellmén
Journal:  Breast Cancer Res Treat       Date:  2008-12-02       Impact factor: 4.872

8.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 9.  Regulation of bone development and extracellular matrix protein genes by RUNX2.

Authors:  Toshihisa Komori
Journal:  Cell Tissue Res       Date:  2009-08-01       Impact factor: 5.249

10.  At-risk populations for osteosarcoma: the syndromes and beyond.

Authors:  George T Calvert; R Lor Randall; Kevin B Jones; Lisa Cannon-Albright; Stephen Lessnick; Joshua D Schiffman
Journal:  Sarcoma       Date:  2012-03-12
View more
  60 in total

Review 1.  Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms.

Authors:  Ning Zhang; Weihua Lou; Fang Ji; Lihua Qiu; Benjamin K Tsang; Wen Di
Journal:  J Cancer Res Clin Oncol       Date:  2016-02-24       Impact factor: 4.553

2.  Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells.

Authors:  Ruizhong Wang; Hua Fang; Qin Fang
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

Review 3.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

4.  Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells.

Authors:  Rutusmita Mishra; Sandip Nathani; Ritu Varshney; Debabrata Sircar; Partha Roy
Journal:  Mol Biol Rep       Date:  2020-10-19       Impact factor: 2.316

5.  Gene function analysis in osteosarcoma based on microarray gene expression profiling.

Authors:  Liang Zhao; Jinghua Zhang; Hongyu Tan; Weidong Wang; Yilin Liu; Ruipeng Song; Limin Wang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.

Authors:  Leisheng Wang; Junbo Ge; Tian Ma; Yanpin Zheng; Shiqiao Lv; Yu Li; Shaoxian Liu
Journal:  Tumour Biol       Date:  2015-07-01

7.  Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells.

Authors:  Yantao Chen; Kunshui Zhang; Yang Li; Qing He
Journal:  Cell Adh Migr       Date:  2016-08-17       Impact factor: 3.405

8.  miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.

Authors:  Meng Xu; Hua Jin; Cheng-Xiong Xu; Bo Sun; Zhi-Gang Song; Wen-Zhi Bi; Yan Wang
Journal:  Mol Ther       Date:  2014-10-08       Impact factor: 11.454

9.  Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt.

Authors:  Zuohong Li; Lesheng Wang; Nan Luo; Yantao Zhao; Jiazhi Li; Qiwei Chen; Yu Tian
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

10.  Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21.

Authors:  Cheng Yang; Guijiang Wang; Jian Yang; Liguo Wang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.